Roland W. Herzog, PhD, has been serving as Riley Children's Foundation Professor of Immunology and Director of the Gene and Cell Therapy Program at the Herman B Wells Center for Pediatric Research at Indiana University since 2018. Further, he served as editor-in-chief of Molecular Therapy - Methods and Clinical Development (2015-2020) and Molecular Therapy (2020-2025). Dr. Herzog holds a PhD in microbiology from Auburn University and pursued postdoctoral research in gene therapy for hemophilia at The Children's Hospital of Philadelphia, followed by faculty appointments at the University of Pennsylvania and at the University of Florida. His research team studies immune response mechanisms in gene therapy and develops adeno-associated viral (AAV) gene therapies and immunotherapies for treatment of genetic diseases such as hemophilia and muscular dystrophy. Dr. Herzog received multiple awards for his research and service to the scientific community, including from the American Society of Gene and Cell Therapy and the National Hemophilia Foundation. Thus far, he has published >280 scientific articles and 3 books.